The 2014 Controlling Cancer Summit
Anti-Cancer Therapeutics
Meeting report from the Euroscicon event: 14th May 2014, London, UK
Meeting Chair:
Dr. Ann White, Senior Research Fellow, University of Southampton, UK
Author: Matthew Trendowski
Department of Biology, Syracuse University, NY, USA
Editor: Dr. Astrid Englezou, Euroscicon Ltd
This meeting report summarizes the talks from the third day (14th May 2014) of Euroscicon’s The 2014 Controlling Cancer Summit, which described anti-cancer therapeutics
Buy from[amazon asin=B00Q3808KA&text=Amazon]
Contents
ABSTRACT
INTRODUCTION
Selected talks
The selective targeting of cell survival pathways in cancer cells
Early oncology drug development - current strategies and future challenges
Translating antibodies engineered with IgE Fc regions to elicit enhanced effector functions for cancer therapy
Patient delay in accessing breast cancer care in a LIC
In vivo drug combination effects of 1’s-1’-acetoxychavicol acetate (ACA) and 1’s-1’-acetoxyeugenol acetate (AEA) from Alpinia conchigera on human breast and oral cancer xenografts
Investigating the efficacy of combining thymoquinone with clinical drugs to enhance cell death in adult t-cell leukemia
The promise of sonodynamic therapy: using ultrasonic irradiation and chemotherapeutic agents as a treatment modality
Reporter bioassay: a novel, bioluminescent cell-based assay for quantifying Fc effector function of therapeutic antibodies
HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation
FKBPL and peptide derivatives and their dual anti-angiogenic and anti-cancer stem cell activity
Targeting leukaemic stem cells to improve treatment of chronic myeloid leukemia
Discussion panel
CONCLUSION
REFERENCES
BIOGRAPHIES
POSTER PRESENTATION
TARGETING INTEGRIN LINKED KINASE ABOLISHES THE PRESENCE OF MOLECULAR AND PHENOTYPIC MARKERS OF EPITHELIAL-MESENCHYMAL TRANSITION
- File Size: 946 KB
- Print Length: 32 pages
- Simultaneous Device Usage: Unlimited
- Publisher: HONNAO (November 23, 2014)
- Sold by: Amazon Digital Services, Inc.
- Language: English
- ASIN: B00Q3808KA
Tags: AFP, ALK-related malignancies, AllergoOncology, Androgen Receptor, anti-angiogenic, anti-cancer stem cell, Antiandrogens, Apoptosis, apoptosis; kinase; leukemia; Mcl-1, astrocytoma genetics, Awareness, BCR-ABL, beta-catenin, Beta-Tubulin isotypes, biomarker, biomarker discovery, biotherapeutics, body image, BRAF, BRCA1, BRCA2, breast, breast cancer, Breast cancer intraoperative radiotherapy, CA-125, CA19.9, Cancer, cancer cure, cancer screening registry, Cancer stem cells, cancerawareness, carcinogen, Catration-Resistant Prostate Cancer, CD44, CEA, cell-mediated immunotherapy, cervical cancer screening, chemoprevention, chemotherapy, Chimeric antigen receptor ErbB family, chromatin remodelling, Chronic Myeloid Leukemia, colorectal cancer, communication, Comprehensive Geriatric Assessment, contraception, CT scanning, diagnosis, drug resistance, drugresistance, e-health, early detection, Early diagnosis, EGFR, Elderly, epidemiology, epigenetic, Epigenetic markers of progression and treatment response in breast cancer, Epigenetics, ErbB receptors, exposure, fertility, FKBPL, fluorophores, Gastrointestinal stromal tumor, glioblastoma, head and neck, HER-2, IgE, IgG, immunochemical test, Immunotherapy, Intraoperative Radiation, KIT, leukemia, linac, Liver Cancer, lung cancer, mAb effector functions, Macrophages, mammography, mammography early detection of breast cancer, MCAD campaign, Melanoma, Microtubule Targeting Chemotherapy, minimal residual disease, molecular targeted therapies, Monocytes/macrophages, Mouth Head and Neck Cancer, MRM3, murine models, Non-small-cell lung carcinoma, NSCLC, Nucleosomes, Oncogenes, oncology, optical diagnosis, Ovarian Cancer, over-diagnosis, overdiagnosis, paediatric lymphoma, Pancreatic Cancer, Pap smear, participation rate and screening, peptide therapeutic, personalised medicine, pre-malignancies, PRM, prostate cancer, Prostate Specific Antigen, proteomics, PSA, Psychosocial Support, quality control, Radiation Therapy, radioisotopes, Reprodutive health, Rhabdoid coloretal tumors, risk, risk assesment, risk stratification, S100, Sarcoma, screen, screening., second line, signal transduction, singl test, Skyline, Solid tumours, SRM/MRM, targeted screening, TAT, therapeutic, TKI, TMT 10-plex, transciption, Trastuzumab, treatment, two consecutive test, tyrosine kinase inhibitors, V600E, Vitamin D, Whole exome sequencing, Wnt signalling, young adults
Follow Us!